Switch to:
More From Other Websites
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Impax Laboratories, Inc. for... Feb 15 2017
Zacks.com featured highlights: General Motors, Citizens Financial Group, Impax Laboratories and... Feb 06 2017
ETFs with exposure to Impax Laboratories, Inc. : February 3, 2017 Feb 03 2017
7 Stocks You Should Sell Right Now Feb 02 2017
Impax Laboratories, Inc. breached its 50 day moving average in a Bullish Manner : IPXL-US : February... Feb 02 2017
Blog Coverage Pfizer Reported Positive Results for Mid-stage Trial for C. difficile Vaccine Jan 27 2017
Impax to Report Fourth Quarter and Full Year 2016 Results on March 1, 2017 Jan 25 2017
U.S. reaches settlement with Endo on pay-for-delay charges Jan 23 2017
FTC settles pay-for-delay lawsuit, files two related complaints Jan 23 2017
Is Impax a Great Stock for Value Investors? Jan 19 2017
CVS takes on Mylan’s EpiPen with much cheaper version of an alternative Jan 15 2017
Fifth Street Asset Management, Cray, CVS Health, Mylan and Impax Laboratories highlighted as Zacks... Jan 13 2017
Biotech Premarket Movers: SGMO, IPXL, PTLA Jan 13 2017
Cheaper Epinephrine: Spend Way Less With This EpiPen Alternative Jan 12 2017
UPDATE 1-CVS slashes price of Impax's EpiPen rival Jan 12 2017
CVS slashes price of Impax's emergency allergy shot Jan 12 2017
Mylan Crushed by Trump, Cigna and CVS -- All In Two Days Jan 12 2017
[$$] Cigna Drops EpiPen Coverage for Generic Jan 12 2017
CVS Debuts Cheap EpiPen Alternative Jan 12 2017
CVS Is the Latest to Rock Mylan's EpiPen Empire Jan 12 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK